Remove FDA Remove Pharma Remove Pharmaceutical products Remove White Paper
article thumbnail

What’s next for Container Closure Integrity Testing?

Pharmaceutical Technology

A vitally important assay used across various stages of drug development and manufacturing, container closure integrity testing (CCIT) involves evaluating packaging systems to determine their ability to protect the stability and sterility of pharmaceutical products. Pharma 4.0. In the fast-approaching era of Pharma 4.0,

article thumbnail

FDA issues continuous manufacturing advice to build an agile pharma industry

Pharmaceutical Technology

On 1 March, the FDA issued the International Council for Harmonisation (ICH) final guidance on the use of continuous manufacturing in drug production. This publication marks the FDA’s proactive steps to ease the pharmaceutical’s industry transition to these advanced processes, states the announcement.